| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Regenxbio Inc. (RGNX) has 14 insiders with recent SEC Form 4 filings, including 0 buys and 78 sells. RGNX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 495.9K | $4.50M | - | |
| CEO | 342.5K | $3.11M | - | |
| Other | 247.9K | $2.25M | - | |
| Other | 215.4K | $1.95M | - | |
| Other | 82.2K | $745.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 24, 2017 | Vasista Vittal79 | Chief Financial Officer | Sell | 3,100 | $21.00 | $65,098.69 | -1.3% | |
| Apr 24, 2017 | Hayden Donald J Jr | Director | Sell | 10,000 | $20.98 | $209,800.00 | -25.9% | |
| May 17, 2016 | Fmr LLC72 | See Remark 1 | Sell | 18,300 | $12.41 | $227,103.00 | -2.9% | |
| May 16, 2016 | Fmr LLC72 | 10% Owner, See Remark 1 | Sell | 16,030 | $11.65 | $186,764.93 | -0.2% | |
| May 12, 2016 | Fmr LLC72 | 10% Owner, See Remark 1 | Sell | 6,711 | $10.85 | $72,833.46 | -0.1% | |
| May 11, 2016 | Fmr LLC72 | 10% Owner, See Remark 1 | Sell | 25,132 | $10.36 | $260,452.83 | -0.2% | |
| May 9, 2016 | Fmr LLC72 | 10% Owner, See Remark 1 | Sell | 10,570 | $9.94 | $105,087.11 | - | |
| May 4, 2016 | Fmr LLC72 | 10% Owner, See Remark 1 | Sell | 1,896 | $10.51 | $19,918.92 | - | |
| May 3, 2016 | Fmr LLC72 | 10% Owner, See Remark 1 | Sell | 6,046 | $10.76 | $65,065.66 | - | |
| Apr 29, 2016 | Fmr LLC72 | 10% Owner, See Remark 1 | Sell | 4,723 | $10.80 | $51,020.17 | -0.3% |